{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:06:22Z","timestamp":1791860782324,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Science and Higher Education","award":["N N402467540"],"award-info":[{"award-number":["N N402467540"]}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["DEC-2011\/03\/N\/NZ5\/00248"],"award-info":[{"award-number":["DEC-2011\/03\/N\/NZ5\/00248"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bbi.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T16:56:10Z","timestamp":1525366570000},"page":"28-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"special_numbering":"C","title":["Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study"],"prefix":"10.1016","volume":"71","author":[{"given":"Dorota","family":"Frydecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Krzystek-Korpacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Lubeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5326-8778","authenticated-orcid":false,"given":"Filip","family":"Stramecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Sta\u0144czykiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Aleksander","family":"Besz\u0142ej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Piotrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Kotowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Szewczuk-Bogus\u0142awska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0386-7940","authenticated-orcid":false,"given":"Edyta","family":"Pawlak-Adamska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u0142a\u017cej","family":"Misiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2018.05.002_b0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1742-2094-9-83","article-title":"Maternal immune activation by poly I: C induces expression of cytokines IL-1beta and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain","volume":"9","author":"Arrode-Bruses","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2018.05.002_b0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pnpbp.2014.11.002","article-title":"Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: implications for neurodevelopmental psychiatric disorders","volume":"57","author":"Ballendine","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2016.05.010","article-title":"Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia","volume":"39","author":"Balotsev","year":"2017","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biopsych.2013.09.023","article-title":"The epidemiologic evidence linking autoimmune diseases and psychosis","volume":"75","author":"Benros","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-017-0962-y","article-title":"Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder","volume":"14","author":"Boerrigter","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2018.05.002_b0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psychres.2017.03.038","article-title":"Oxidative and nitrosative stress biomarkers in chronic schizophrenia","volume":"253","author":"Boll","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1176\/appi.ajp.161.5.889","article-title":"Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring","volume":"161","author":"Brown","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neubiorev.2017.03.003","article-title":"Acute variations of cytokine levels after antipsychotic treatment in drug-naive subjects with a first-episode psychosis: a meta-analysis","volume":"77","author":"Capuzzi","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2018.05.002_b0045","doi-asserted-by":"crossref","first-page":"15267","DOI":"10.1074\/jbc.M116.714824","article-title":"Neutralization of RANTES and eotaxin prevents the loss of dopaminergic neurons in a mouse model of Parkinson Disease","volume":"291","author":"Chandra","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2018.05.002_b0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","article-title":"Serum and gene expression profile of cytokines in first-episode psychosis","volume":"31","author":"Di Nicola","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2018.05.002_b0055","first-page":"134","article-title":"Inflammatory Markers in Recent Onset Psychosis and Chronic Schizophrenia","volume":"42","author":"Dickerson","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2018.05.002_b0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2013.10.019","article-title":"Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway","volume":"151","author":"Dimitrov","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.schres.2010.05.014","article-title":"Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8","volume":"121","author":"Ellman","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pnpbp.2013.06.011","article-title":"Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers","volume":"46","author":"Fernandez-Egea","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0075","first-page":"449","article-title":"Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation","volume":"265","author":"Frydecka","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2018.05.002_b0080","series-title":"Conducting Quantitative Synthesis When Comparing Medical Interventions: AHRQ and the Effective Health Care Program","author":"Fu","year":"2008"},{"key":"10.1016\/j.bbi.2018.05.002_b0085","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.psychres.2015.08.018","article-title":"Angiotensin converting enzyme activity is positively associated with IL-17a levels in patients with schizophrenia","volume":"229","author":"Gadelha","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1742-2094-11-128","article-title":"Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain","volume":"11","author":"Gil-Pisa","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2018.05.002_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.bbi.2018.05.002_b0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2015.08.027","article-title":"Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index","volume":"169","author":"Haring","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1742-2094-8-77","article-title":"CCL2\/MCP-1 modulation of microglial activation and proliferation","volume":"8","author":"Hinojosa","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2018.05.002_b0110","article-title":"Abnormalities in chemokine levels in schizophrenia and their clinical correlates","author":"Hong","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0115","first-page":"439","article-title":"Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients","volume":"49","author":"Kaminska","year":"2001","journal-title":"Archivum Immunologiae et Therapiae Experimentalis"},{"key":"10.1016\/j.bbi.2018.05.002_b0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2018.05.002_b0125","article-title":"Accelerated aging in schizophrenia and related disorders: future research","author":"Kirkpatrick","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0130","first-page":"287","article-title":"Pretreatment serum MCP-1 level predicts response to risperidone in schizophrenia","volume":"29","author":"Lin","year":"2017","journal-title":"Shanghai Arch. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0920-9964(00)00094-3","article-title":"Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor","volume":"54","author":"Maes","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0140","doi-asserted-by":"crossref","first-page":"e0125112","DOI":"10.1371\/journal.pone.0125112","article-title":"Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis","volume":"10","author":"Mantyla","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2018.05.002_b0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2012.03.004","article-title":"Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes","volume":"137","author":"Martinez-Cengotitabengoa","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0150","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/archpsyc.1991.01810320088015","article-title":"A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system","volume":"48","author":"McGuffin","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b9000","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.psychres.2016.01.077","article-title":"Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism","volume":"238","author":"Misiak","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0160","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.bbi.2018.05.002_b0165","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","article-title":"Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis","volume":"41","author":"Mondelli","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2018.05.002_b0170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2014.04.041","article-title":"Neuroinflammation and white matter pathology in schizophrenia: systematic review","volume":"161","author":"Najjar","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0175","article-title":"Abnormal levels of vascular endothelial biomarkers in schizophrenia","author":"Nguyen","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2018.05.002_b0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2016.02.025","article-title":"Individual and combined effects of maternal anemia and prenatal infection on risk for schizophrenia in offspring","volume":"172","author":"Nielsen","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0185","first-page":"1","article-title":"High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance","author":"Noto","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0190","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.psychres.2007.11.014","article-title":"Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia","volume":"160","author":"O'Brien","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0195","first-page":"69","article-title":"Effects of transformations on significance of the Pearson T-Test","volume":"11","author":"Omokri","year":"2015","journal-title":"IOSR J. Math."},{"key":"10.1016\/j.bbi.2018.05.002_b0200","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/mp.2015.96","article-title":"Association of serum VEGF levels with prefrontal cortex volume in schizophrenia","volume":"21","author":"Pillai","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0205","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neubiorev.2014.02.001","article-title":"Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies","volume":"42","author":"Stuart","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2018.05.002_b0215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fncel.2015.00357","article-title":"Systematic review of the neurobiological relevance of chemokines to psychiatric disorders","volume":"9","author":"Stuart","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2018.05.002_b0220","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/mp.2016.90","article-title":"Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review","volume":"21","author":"Trepanier","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2018.05.002_b0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0230","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.schres.2013.04.003","article-title":"Differential correlations between plasma oxytocin and social cognitive capacity and bias in schizophrenia","volume":"147","author":"Walss-Bass","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2018.05.002_b0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13287-017-0474-9","article-title":"CCL11 promotes migration and proliferation of mouse neural progenitor cells","volume":"8","author":"Wang","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbi.2018.05.002_b0240","unstructured":"Wells, G.A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., Tugwell, P., 2000. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses."},{"key":"10.1016\/j.bbi.2018.05.002_b0245","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cyto.2012.02.013","article-title":"Monocyte chemoattractant protein-1 in schizophrenia: -2518A\/G genetic variant and protein levels in Armenian population","volume":"58","author":"Zakharyan","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2018.05.002_b0250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbi.2015.09.014","article-title":"Interaction of BDNF with cytokines in chronic schizophrenia","volume":"51","author":"Zhang","year":"2016","journal-title":"Brain Behav. Immun."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159118301739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159118301739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:49:15Z","timestamp":1760168955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159118301739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":51,"alternative-id":["S0889159118301739"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2018.05.002","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}